𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Detection of cytokeratin-positive cells in the bone marrow of breast cancer patients undergoing adjuvant therapy

✍ Scribed by Sven Becker; Graziella Becker-Pergola; Diethelm Wallwiener; Erich-Franz Solomayer; Tanja Fehm

Publisher
Springer US
Year
2005
Tongue
English
Weight
172 KB
Volume
97
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The prognostic impact of cytokeratin-pos
The prognostic impact of cytokeratin-positive cells in bone marrow of patients with localized prostate cancer
✍ Wolfgang Lilleby; Jahn M. Nesland; Sophie D. FossΓ₯; Goran Torlakovic; HΓ₯kon Waeh πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 145 KB πŸ‘ 1 views

## Abstract Our study evaluates the prognostic significance of the cytokeratin‐positive mononuclear cells (CK+ cells) in the bone marrow (BM) and peripheral blood (PB) as detected by immunocytochemistry in patients with locoregionally confined prostate cancer. BM and PB samples were obtained from 6

Persistence of bone marrow micrometastas
Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: Results at 4 years
✍ Martin J. Slade; Anjana Singh; Brendan M. Smith; Gopi Tripuraneni; Emma Hall; Cl πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 108 KB

We have previously developed a quantitative PCR (QPCR) technique for the detection of cytokeratin 19 (CK19) transcripts in blood and bone marrow and compared this to immunocytochemistry (ICC). Together, both have shown promise for monitoring therapeutic efficacy in patients with metastatic breast ca

Monoclonal antibodies for detection of o
Monoclonal antibodies for detection of occult carcinoma cells in bone marrow of breast cancer patients
✍ Georgiana Ellis; Marina Ferguson; Elaine Yamanaka; Robert B. Livingston; Allen M πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 645 KB

Metastases develop in 30% to 40% of patients with operable breast cancer. Investigators have reported on the detection of occult micrometastases in bone marrow using an antibody to epithelial membrane antigen (EMA) and have since reported prognostic significance for these antibody-detected cells. In